Literature DB >> 18299523

Transmissible spongiform encephalopathy in the 21st century: neuroscience for the clinical neurologist.

Paul Brown1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18299523     DOI： 10.1212/01.wnl.0000302186.10596.f6

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  9 in total

1.  Wernicke encephalopathy and Creutzfeldt-Jakob disease.

Authors:  A Bertrand; J P Brandel; Y Grignon; V Sazdovitch; D Seilhean; B Faucheux; N Privat; J L Brault; A Vital; E Uro-Coste; M Pluot; F Chapon; C A Maurage; F Letournel; H Vespignani; G Place; C F Degos; K Peoc'h; S Haïk; J J Hauw
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

2.  Reply: LATE to the PART-y.

Authors:  Peter T Nelson; Dennis W Dickson; John Q Trojanowski; Clifford R Jack; Patricia A Boyle; Konstantinos Arfanakis; Rosa Rademakers; Irina Alafuzoff; Johannes Attems; Carol Brayne; Ian T S Coyle-Gilchrist; David W Fardo; Margaret E Flanagan; Glenda Halliday; Sally Hunter; Gregory A Jicha; Yuriko Katsumata; Claudia H Kawas; C Dirk Keene; Gabor G Kovacs; Walter A Kukull; Allan I Levey; Nazanin Makkinejad; Thomas J Montine; Melissa E Murray; Sukriti Nag; William W Seeley; Reisa A Sperling; Charles L White; Julie A Schneider
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

Review 3.  Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt-Jakob disease: an evidence-based approach.

Authors:  Michael B Coulthart; Gerard H Jansen; Neil R Cashman
Journal:  CMAJ       Date:  2014-01-20       Impact factor: 8.262

4.  Could immunomodulation be used to prevent prion diseases?

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Anti Infect Ther       Date:  2012-03       Impact factor: 5.091

Review 5.  Immunomodulation for prion and prion-related diseases.

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Vaccines       Date:  2010-12       Impact factor: 5.217

6.  Estimating prion concentration in fluids and tissues by quantitative PMCA.

Authors:  Baian Chen; Rodrigo Morales; Marcelo A Barria; Claudio Soto
Journal:  Nat Methods       Date:  2010-05-30       Impact factor: 28.547

7.  Prion disease blood test using immunoprecipitation and improved quaking-induced conversion.

Authors:  Christina D Orrú; Jason M Wilham; Lynne D Raymond; Franziska Kuhn; Björn Schroeder; Alex J Raeber; Byron Caughey
Journal:  MBio       Date:  2011-05-10       Impact factor: 7.867

8.  Styryl-based and tricyclic compounds as potential anti-prion agents.

Authors:  Erika Chung; Frances Prelli; Stephen Dealler; Woo Sirl Lee; Young-Tae Chang; Thomas Wisniewski
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

Review 9.  Interaction between pathogenic proteins in neurodegenerative disorders.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.